HIKAL Stock View

Hikal Ltd
stock-view-header

₹ 278.9

icon 0.40 | 0.14
Market Cap ₹( Cr.)
34,382.41
Proj. P/E (x)
50.71
Proj. P/BV (x)
Proj. ROE (%)
5.90
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)
18,077.00

Stock View

STRONG BUY

Last Updated On.
25-Feb-2024
 

The average score for Hikal Ltd stands at 4 against 2, three months back.

Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-viral, anti-inflammatory, analgesic and anti-parasitic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone and NSAID. Its crop protection product categories include algaecide, biocide, fungicide, herbicide, insecticide and intermediate.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
293.00
100 DMA(₹)
286.99
200 DMA(₹)
293.80
52 Weeks Range
258.60     328.60

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required